DTL
NTLA icon

Dynamic Technology Lab’s Intellia Therapeutics NTLA Stock Holding History

Dynamic Technology Lab’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
+11,287
New +$144K 0.02% 773
2023
Q4 		– Sell
-12,280
Closed -$388K – 1296
2023
Q3 		$388K Buy
12,280
+6,900
+128% +$268K 0.04% 573
2023
Q2 		$219K Buy
+5,380
New +$218K 0.03% 806
2022
Q4 		– Sell
-8,130
Closed -$455K – 1382
2022
Q3 		$455K Buy
+8,130
New +$504K 0.04% 667
2022
Q2 		– Sell
-3,470
Closed -$252K – 1407
2022
Q1 		$252K Buy
+3,470
New +$294K 0.03% 864
2017
Q3 		– Sell
-10,454
Closed -$167K – 1274
2017
Q2 		$167K Buy
+10,454
New +$146K 0.03% 907

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return